These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19768421)

  • 21. Prioritization of influenza pandemic vaccination to minimize years of life lost.
    Miller MA; Viboud C; Olson DR; Grais RF; Rabaa MA; Simonsen L
    J Infect Dis; 2008 Aug; 198(3):305-11. PubMed ID: 18558871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tetravaccine--new fundamental approach to prevention of influenza pandemic].
    Onishchenko GG; Zverev VV; Katlinskiĭ AV; Semchenko AV; Korovkin SA; Mel'nikov SIa; Mironov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):15-9. PubMed ID: 17882832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparing for pandemic vaccination: an international policy agenda for vaccine development.
    Fedson DS
    J Public Health Policy; 2005 Apr; 26(1):4-29. PubMed ID: 15906873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study.
    Simpson CR; Lone N; McMenamin J; Gunson R; Robertson C; Ritchie LD; Sheikh A
    Health Technol Assess; 2015 Oct; 19(79):1-32. PubMed ID: 26450686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
    Reed C; Meltzer MI; Finelli L; Fiore A
    Vaccine; 2012 Mar; 30(11):1993-8. PubMed ID: 22226861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance.
    Davey VJ; Glass RJ; Min HJ; Beyeler WE; Glass LM
    PLoS One; 2008 Jul; 3(7):e2606. PubMed ID: 18596963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza pandemic preparedness in France: modelling the impact of interventions.
    Doyle A; Bonmarin I; Lévy-Bruhl D; Le Strat Y; Desenclos JC
    J Epidemiol Community Health; 2006 May; 60(5):399-404. PubMed ID: 16614329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass vaccination for annual and pandemic influenza.
    Schwartz B; Wortley P
    Curr Top Microbiol Immunol; 2006; 304():131-52. PubMed ID: 16989268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
    Ford SM; Grabenstein JD
    Pharmacotherapy; 2006 Mar; 26(3):312-22. PubMed ID: 16503711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of influenza vaccine strains and developing pandemic vaccines.
    Wood JM
    Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing vaccines against pandemic influenza.
    Wood JM
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparing for an influenza pandemic: vaccine prioritization.
    Temte JL
    Fam Pract Manag; 2006 Jan; 13(1):32-4. PubMed ID: 16457462
    [No Abstract]   [Full Text] [Related]  

  • 39. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
    Johns MC; Eick AA; Blazes DL; Lee SE; Perdue CL; Lipnick R; Vest KG; Russell KL; DeFraites RF; Sanchez JL
    PLoS One; 2010 May; 5(5):e10722. PubMed ID: 20502705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.